| MCX: PRTK | |
| Founded | 1990 |
| Headquarters | , Russia |
| Revenue | $4.43 billion1 (2017) |
| $138 million1 (2017) | |
| $101 million1 (2017) | |
| Total assets | $2.32 billion1 (2017) |
| Total equity | $579 million1 (2017) |
Number of employees | 15,300 |
Protek (Russian: Протек) is a Russian company that includes drug manufacturing, retail, and distribution. It is one of the largest pharmaceutical companies of Russia.2 It was founded in 1990 by Vadim Yakunin and Grigor Khachaturov.3 In 2022, the company's revenue in Russia amounted to 257 billion rubles.4
References
References
- http://www.protek-group.ru/upload/iblock/761/PAO-PROTEK_MSFO_KFO_2017.pdf.
{{cite web}}: Missing or empty|title=(help) - "Russia - Country Commercial Guide - Pharmaceuticals". International Trade Administration (which operates trade.gov). 2020-11-14. Retrieved June 17, 2021.
- "Russian drug firm Protek in talks with new partner". Reuters. Archived from the original on 2022-12-18.
- "АО ЦВ Протек". www.rusprofile.ru (in Russian). Retrieved 2023-11-30.